Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells

Vanadium compounds were studied in recent years by considering them as a representative of a new class of non-platinum metal anticancer drugs. However, a few challenges still remain in the discovery of new molecular targets of these new metallodrugs. Studies on cell signaling pathways related to van...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: León, Ignacio Esteban, Díez, Paula, Baran, Enrique José, Etcheverry, Susana Beatriz, Fuentes, Manuel
Formato: Conjunto de datos
Lenguaje:Inglés
Publicado: 2020
Materias:
AKT
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/108112
https://doi.org/10.35537/10915/108112
Aporte de:
id I19-R120-10915-108112
record_format dspace
spelling I19-R120-10915-1081122023-04-26T12:46:46Z http://sedici.unlp.edu.ar/handle/10915/108112 https://doi.org/10.35537/10915/108112 Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells León, Ignacio Esteban Díez, Paula Baran, Enrique José Etcheverry, Susana Beatriz Fuentes, Manuel 2020-11-02T17:37:31Z 2017 en Ciencias Exactas Química Ciencias Médicas https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/3 vanadium AKT cancer Osteosarcoma Vanadium compounds were studied in recent years by considering them as a representative of a new class of non-platinum metal anticancer drugs. However, a few challenges still remain in the discovery of new molecular targets of these new metallodrugs. Studies on cell signaling pathways related to vanadium compounds have scarcely been reported and so far this information is highly critical for identifying novel targets that play a key role in the antitumor actions of vanadium complexes. This research deals with the alterations in the intracellular signaling pathways promoted by an oxovanadium(IV) complex with the clioquinol (5-chloro-7-iodo-8-quinolinol), VO(CQ)<sub>2</sub>, on a human osteosarcoma cell line (MG-63). Herein are reported, for the first time, the antitumor properties of VO(CQ)<sub>2</sub> and the relative abundance of 224 proteins (which are involved in most of the common intracellular pathways) to identify novel targets of the studied complex. Besides, full-length human recombinant AKT1 kinase was produced by using an IVTT system to evaluate the variation of relative tyrosin-phosphorylation levels caused by this compound. The results of the differential protein expression levels reveal several up-regulated proteins such as CASP3, CASP6, CASP7, CASP10, CASP11, Bcl-x, DAPK and down-regulated ones, such as PKB/AKT, DIABLO, among others. Moreover, cell signaling pathways involved in several altered pathways related to the PKC and AP2 family have been identified in both treatments (2.5 and 10 μM) suggesting the crucial antitumoral role of VO(CQ)<sub>2</sub>. Finally, it has been demonstrated that this compound (10 μM, 6 h) triggers a decrease of 2-fold in <i>in situ</i> AKT1 expression. Fil: Baran, Enrique José. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Química Inorgánica; Argentina. Fil: Etcheverry, Susana Beatriz. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Química Inorgánica; Argentina. Fil: León, Ignacio Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Química Inorgánica "Dr. Pedro J. Aymonino". Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Química Inorgánica "Dr. Pedro J. Aymonino"; Argentina Facultad de Ciencias Exactas Centro de Química Inorgánica Conjunto de datos Conjunto de datos http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International (CC BY 4.0) application/pdf
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Ciencias Exactas
Química
Ciencias Médicas
https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/3
vanadium
AKT
cancer
Osteosarcoma
spellingShingle Ciencias Exactas
Química
Ciencias Médicas
https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/3
vanadium
AKT
cancer
Osteosarcoma
León, Ignacio Esteban
Díez, Paula
Baran, Enrique José
Etcheverry, Susana Beatriz
Fuentes, Manuel
Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
topic_facet Ciencias Exactas
Química
Ciencias Médicas
https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/3
vanadium
AKT
cancer
Osteosarcoma
description Vanadium compounds were studied in recent years by considering them as a representative of a new class of non-platinum metal anticancer drugs. However, a few challenges still remain in the discovery of new molecular targets of these new metallodrugs. Studies on cell signaling pathways related to vanadium compounds have scarcely been reported and so far this information is highly critical for identifying novel targets that play a key role in the antitumor actions of vanadium complexes. This research deals with the alterations in the intracellular signaling pathways promoted by an oxovanadium(IV) complex with the clioquinol (5-chloro-7-iodo-8-quinolinol), VO(CQ)<sub>2</sub>, on a human osteosarcoma cell line (MG-63). Herein are reported, for the first time, the antitumor properties of VO(CQ)<sub>2</sub> and the relative abundance of 224 proteins (which are involved in most of the common intracellular pathways) to identify novel targets of the studied complex. Besides, full-length human recombinant AKT1 kinase was produced by using an IVTT system to evaluate the variation of relative tyrosin-phosphorylation levels caused by this compound. The results of the differential protein expression levels reveal several up-regulated proteins such as CASP3, CASP6, CASP7, CASP10, CASP11, Bcl-x, DAPK and down-regulated ones, such as PKB/AKT, DIABLO, among others. Moreover, cell signaling pathways involved in several altered pathways related to the PKC and AP2 family have been identified in both treatments (2.5 and 10 μM) suggesting the crucial antitumoral role of VO(CQ)<sub>2</sub>. Finally, it has been demonstrated that this compound (10 μM, 6 h) triggers a decrease of 2-fold in <i>in situ</i> AKT1 expression.
format Conjunto de datos
Conjunto de datos
author León, Ignacio Esteban
Díez, Paula
Baran, Enrique José
Etcheverry, Susana Beatriz
Fuentes, Manuel
author_facet León, Ignacio Esteban
Díez, Paula
Baran, Enrique José
Etcheverry, Susana Beatriz
Fuentes, Manuel
author_sort León, Ignacio Esteban
title Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
title_short Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
title_full Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
title_fullStr Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
title_full_unstemmed Data from: Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
title_sort data from: decoding the anticancer activity of vo-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells
publishDate 2020
url http://sedici.unlp.edu.ar/handle/10915/108112
https://doi.org/10.35537/10915/108112
work_keys_str_mv AT leonignacioesteban datafromdecodingtheanticanceractivityofvoclioquinolcompoundthemechanismofactionandcelldeathpathwaysinhumanosteosarcomacells
AT diezpaula datafromdecodingtheanticanceractivityofvoclioquinolcompoundthemechanismofactionandcelldeathpathwaysinhumanosteosarcomacells
AT baranenriquejose datafromdecodingtheanticanceractivityofvoclioquinolcompoundthemechanismofactionandcelldeathpathwaysinhumanosteosarcomacells
AT etcheverrysusanabeatriz datafromdecodingtheanticanceractivityofvoclioquinolcompoundthemechanismofactionandcelldeathpathwaysinhumanosteosarcomacells
AT fuentesmanuel datafromdecodingtheanticanceractivityofvoclioquinolcompoundthemechanismofactionandcelldeathpathwaysinhumanosteosarcomacells
_version_ 1765659801133514752